Publicaciones en las que colabora con MANUEL PRAGA TERENTE (16)

2019

  1. Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials

    The Lancet Diabetes and Endocrinology, Vol. 7, Núm. 2, pp. 128-139

  2. Returning to haemodialysis after kidney allograft failure: A survival study with propensity score matching

    Nephrology Dialysis Transplantation, Vol. 34, Núm. 4, pp. 667-672

2018

  1. Proton Pump Inhibitor Usage and the Risk of Mortality in Hemodialysis Patients

    Kidney International Reports, Vol. 3, Núm. 2, pp. 374-384

2017

  1. The Combination of Beta Blockers and Renin-Angiotensin System Blockers Improves Survival in Incident Hemodialysis Patients: A Propensity-Matched Study

    Journal of Computational Design and Engineering, Vol. 4, Núm. 3, pp. 665-675

2014

  1. Características clínicas, analíticas y de bioimpedancia de los pacientes en hemodiálisis persistentemente hiperhidratados

    Nefrologia, Vol. 34, Núm. 6, pp. 716-723

2013

  1. 25 (OH) vitamin D levels and renal disease progression in patients with type 2 diabetic nephropathy and blockade of the renin-angiotensin system

    Clinical Journal of the American Society of Nephrology, Vol. 8, Núm. 11, pp. 1870-1876

  2. Compliance with mineral metabolism targets in haemodialysis patients: Moving backwards?

    Blood Purification, Vol. 36, Núm. 2, pp. 122-131

  3. Effect of dual blockade of the renin-angiotensin system on the progression of type 2 diabetic nephropathy: A randomized trial

    American Journal of Kidney Diseases, Vol. 61, Núm. 2, pp. 211-218

  4. Type of vascular access and survival among very elderly hemodialysis patients

    Nephron - Clinical Practice, Vol. 124, Núm. 1-2, pp. 47-53

2012

  1. Epidemiological study of 7316 patients on haemodialysis treated in FME clinics in Spain, using data from the EuCliD® database: Results from years 2009-2010

    Nefrologia, Vol. 32, Núm. 6, pp. 743-753

2007

  1. Tacrolimus monotherapy in membranous nephropathy: A randomized controlled trial

    Kidney International, Vol. 71, Núm. 9, pp. 924-930

2006

  1. Dual blockade of the renin-angiotensin system in the progression of renal disease: The need for more clinical trials

    Journal of the American Society of Nephrology

  2. Nefrología basada en investigación clínica: Bases conceptuales para la constitución de un grupo de trabajo en Nefrología Basada en la Evidencia de la Sociedad Española de Nefrología

    Nefrologia, Vol. 26, Núm. 2, pp. 163-172

2005

  1. Farmacogenética del sistema de la angiotensina en la nefropatía no diabética

    Nefrologia, Vol. 25, Núm. 4, pp. 381-386

  2. The reno-protective effect of the dual blockade of the renin angiotensin system (RAS)

    Current Pharmaceutical Design, Vol. 11, Núm. 10, pp. 1291-1300

2003

  1. Antiproteinuric efficacy of losartan in comparison with amplodipine in non-diabetic proteinuric renal diseases: A double-blind, randomized clinical trial

    Nephrology Dialysis Transplantation, Vol. 18, Núm. 9, pp. 1806-1813